We are live on ! Find out more
FEED

ENvue Medical Inc

6 hedge funds and large institutions have $9.5K invested in ENvue Medical Inc in 2025 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

20% more funds holding

Funds holding: 56 (+1)

0.14% more ownership

Funds ownership: 0.08%0.21% (+0.14%)

47% less capital invested

Capital invested by funds: $18.1K → $9.5K (-$8.58K)

Holders
6
Holders Change
+1
Holders Change %
+20%
% of All Funds
0.08%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
3
Reduced
2
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Morgan Stanley
1
Morgan Stanley
New York
$5.64K +$6.75K +897 +871%
TRCT
2
Tower Research Capital (TRC)
New York
$3.54K +$3.02K +401 +177%
UBS Group
3
UBS Group
Switzerland
$198 -$10K -1,335 -97%
SS
4
SBI Securities
Japan
$85 +$113 +15 New
Bank of America
5
Bank of America
North Carolina
$34 +$38 +5 +500%
Citigroup
6
Citigroup
New York
$6 -$1.87K -249 -100%
Fidelity Investments
7
Fidelity Investments
Massachusetts
-$1

FEED Hedge Fund Activity: Q3 2025 in Review

6 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in ENvue Medical Inc (FEED) for Q3 2025, worth a combined $9.5K — down 47% from $18.1K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new FEED positions and 0 closed out — a net gain of 1 holder — while 3 added to existing stakes and 2 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $6.75K. The largest seller was UBS Group, cutting an estimated $10K.

  • 6 institutional investors held ENvue Medical Inc (FEED) as of Q3 2025, up from 5 in Q2 2025.
  • Funds reported $9.5K of ENvue Medical Inc stock for Q3 2025, down 47% quarter-over-quarter.
  • 1 fund opened new ENvue Medical Inc positions in Q3 2025 and 0 closed out, a net change of +1 holder.
  • The largest ENvue Medical Inc buyer in Q3 2025 was Morgan Stanley, an estimated $6.75K added.
  • The largest ENvue Medical Inc seller in Q3 2025 was UBS Group, an estimated $10K sold.

Based on aggregated 13F filings for Q3 2025.